C URRENT OPINION Regulatory B cells, interleukin-10, and atherosclerosis
Hong Lu and Alan Daugherty Activation of immune cells is increasingly credited as an important feature of atherosclerotic development. B lymphocytes play critical roles in the adaptive immune responses and their roles in mechanisms of atherosclerotic lesion formation have been studied extensively. This Bimonthly Update summarizes two recent publications [1 && ,2 && ] that report conflicting results of B lymphocyte-specific interleukin (IL)-10 effects on atherosclerosis.
IL-10 is deemed to be an anti-inflammatory cytokine [3] [4] [5] . Earlier studies by Mallat and colleagues demonstrated that secretion of IL-10 from regulatory T lymphocytes or macrophages reduced atherosclerotic development in both apolipoprotein E (Apoe) À/À and LDL receptor (Ldlr À/À ) mice [6] [7] [8] . Regulatory B lymphocytes also secrete IL-10. A recent study reported that reduced regulatory B lymphocytes in aortic tissues were accompanied by reductions of IL-10, and augmentation of atherosclerosis in Apoe À/À mice [9] . On the basis of this premise, Strom et al. [1 && ] determined whether regulatory B lymphocytes would reduce atherosclerotic development in mice. B lymphocytes isolated from subiliac and para-aortic lymph nodes of mice were adoptively transferred into female Apoe À/À mice fed a normal laboratory diet. Subsequently, left carotid artery injury was induced by placement of a perivascular collar. Adoptive transfer of lymph node-derived B lymphocytes led to a profound reduction of atherosclerotic development. Inhibition of IL-10 using a neutralizing antibody, or adoptive transfer of IL-10 deficient B lymphocytes, ablated the antiatherogenic effect of lymph node B lymphocytes. Further study demonstrated that CD21 hi CD23 hi CD24 hi regulatory B cells were attributed to these protective effects, which were also associated with increases of plasma IL-10 concentrations [1 && ]. On the basis of these data, it was concluded that regulatory B lymphocytes attenuate neointimal formation of atherosclerosis through an IL-10 mediated mechanism.
In In this study, chimeric mice were generated using a conventional bone marrow transplantation approach [10] . Male Ldlr À/À mice were irradiated and reconstituted with bone marrow-derived cells from mMT mice (do not have mature B lymphocytes because of disruption of the membrane exon of the mu heavy chain gene) and IL-10 deficient mice to generate a chimeric system in which IL-10 deficiency was restricted to B lymphocytes as demonstrated previously [3] . Atherosclerotic lesions in both aortic root and aortic arch regions were assessed after 8 weeks of a saturated fat-enriched (21% wt/wt fat) diet feeding, which predominantly represented the early stage of atherosclerotic development. Despite marked reductions of IL-10 in regulatory B lymphocytes, the size and cellular contents of atherosclerotic lesions in either region was not different in mice repopulated with IL-10 deficient B lymphocytes compared with mice repopulated with IL-10 wild type B lymphocytes [2 && ]. There are several differences between these two studies, including the following: first, different mouse strains (female Apoe À/À mice fed a normal laboratory diet [1 && ] versus male Ldlr À/À mice fed a saturated fat-enriched diet [2 && ]), second, different mechanisms of atherosclerotic development (neointimal formation [1 && ] versus lesions with predominant presence of lipid-laden macrophages [2 their conflicting findings add another challenging layer to understand the complex mechanisms of regulatory B lymphocytes in the development of atherosclerosis. Of clinical relevance, it will also be interesting in determining how currently approved drugs (e.g., rituximab and belimumab) for autoimmune diseases targeting on B lymphocyte markers contribute to atherosclerosis development [11] .
